Pharmaceutical News

RSS

Drugs used to control BP associated with lower risk of heart failure in diabetic patients

Two drugs, telmisartan and valsartan, which are used to reduce blood pressure in people with diabetes, are associated with a lower risk of hospitalization for heart attack, stroke or heart failure, according to a study published in CMAJ (Canadian Medical Association Journal).

9 Jul 2013

Soligenix announces personalized medicine collaboration with SciClone

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced a personalized medicine collaboration with SciClone Pharmaceuticals in the Company's oral mucositis clinical program with SGX942.

8 Jul 2013

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

COTI-2 is a computer-designed small molecule that was discovered by our artificial intelligence drug discovery platform called CHEMSAS.

8 Jul 2013

Hemp signs distribution agreement with CleanPath for new memory enhancing nutraceutical

Hemp, Inc. announces its first $200,000 sale after inking an exclusive agreement with CleanPath Resources Corp. This agreement is for CleanPath to distribute Hemp, Inc.'s life-changing nutraceutical, "Focus", which is designed to support "Clearer Thinking" and "Improve Memory".

8 Jul 2013

AIFA grants market access for CTI's PIXUVRI to treat patients with aggressive B-cell NHL

Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).

8 Jul 2013

Betaine boosts athletic performance by nearly 6%, study finds

According to a study supervised by Ithaca College's Exercise and Sport Sciences Chair Thomas Swensen, betaine—a nutrient found in shellfish and beets—boosts athletic performance by nearly six percent when added to a sports drink.

6 Jul 2013

Bioniche, Paladin close debt refinancing agreement and sign first licensing deal for Urocidin

Bioniche Life Sciences Inc. and Paladin Labs Inc. today announced the official closing of the various agreements associated with a comprehensive strategic collaboration to refinance and increase Bioniche's debt, provide new equity, and enter into the first licensing deal for Bioniche's Phase III bladder cancer product - Urocidin.

6 Jul 2013

Scientists explore biomedical applications in implants, drug delivery for hydrogel

It's squishy, synthetic, flexible, mostly water and almost as tough as rubber. No, it's not "flubber" - it's a hydrogel, and now scientists at The University of Akron are exploring new biomedical uses for this polymer-based product.

6 Jul 2013

St. Michael Hospital receives $4.7M grant to conduct policy-driven prescription drug research

An Ontario-wide research network based at St. Michael's Hospital has received a three-year, $4.7 million grant from the province of Ontario to conduct policy-driven prescription drug research.

6 Jul 2013

New study could lead to better and more targeted drugs for arthritis and cancer

The increased risk of heart attack or stroke associated with many arthritis drugs may be avoidable, according to a new international study co-authored by researchers at Imperial College London.

5 Jul 2013

Researchers develop new tool to promote improved drug development

Researchers at Karolinska Institutet in Sweden have developed the first method for directly measuring the extent to which drugs reach their targets in the cell.

5 Jul 2013

Oncologist urges drug companies to include key information in cancer drug labels

In the July 10th issue of The New England Journal of Medicine, Dr. Basch calls for pharmaceutical manufacturers to collect rigorous information on how drugs impact symptoms and quality of life starting early in drug development, and for the U.S. Food and Drug Administration (FDA) to include this information in drug labels.

5 Jul 2013

Duke researchers solve some mysteries related to the use of aspirin

Aspirin has been widely used for more than 50 years as a common, inexpensive blood thinner for patients with heart disease and stroke, but doctors have little understanding of how it works and why some people benefit and others don't.

4 Jul 2013

Gerovital H3 may be making a comeback, warns BUSM researcher

Despite it being more than 30 years since the "fountain of youth drug" Gerovital H3 was banned in the United States, it may be making a comeback. In an editorial published in this month's Journal of the American Geriatrics Society BUSM researcher Thomas Perls, MD, points out that a few U.S.-based anti-aging and longevity clinics have begun to advertise Gerovital H3 in pill form and as intravenous infusions despite the fact that the U.S. Food and Drug Administration banned it in 1982.

4 Jul 2013

Employers worry they'll pay bill for those exempt from contraceptive mandate

Businesses are concerned that non-religious employers will end up covering the bill for religious groups that refuse to pay for contraception for their employees. Meanwhile, church leaders continue their push to broaden the exemption from the contraception coverage rule.

4 Jul 2013

GAPVAC aims to develop personalized therapeutic vaccines for cancer

A highly innovative project supported by a €6 million European Union Framework 7 (EU FP7) program grant to develop a novel class of therapeutic cancer vaccines is now under way.

4 Jul 2013

FDA approves Orexo's Zubsolv for people suffering from opioid dependence

Orexo today announced that it has received approval from the U.S. Food and Drug Administration for Zubsolv (buprenorphine/naloxone) sublingual tablet CIII.

4 Jul 2013

Research shows lower daily dose of HIV drug therapy suppresses virus

Millions more people could get access to life-saving HIV drug therapy, following a landmark study led by Australian researchers based at the Kirby Institute at the University of New South Wales (UNSW).

4 Jul 2013

Scientists uncover easy strategies to prevent harmful side-effects of antibiotics responses

A team of scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University has discovered why long-term treatment with many common antibiotics can cause harmful side effects-and they have uncovered two easy strategies that could help prevent these dangerous responses.

4 Jul 2013

Viewpoints: Dems' abortion policies on the wrong side of public opinion; Doctors need to be more accurate in death reports

Last week saw two major developments in the legal and political battle over the Obama administration's sound decision to require most employers to provide free insurance coverage of contraceptives for women under the new health care law - one of them positive and the other a blow to the mandate and to religious liberty (7/1).

3 Jul 2013

Pharmaceutical News

Drugs used to control BP associated with lower risk of heart failure in diabetic patients

Soligenix announces personalized medicine collaboration with SciClone

p53 restoration of function drug candidate: an interview with Dr. Wayne Danter, MD, FRCPC President and CEO of Critical Outcome Technologies

Hemp signs distribution agreement with CleanPath for new memory enhancing nutraceutical

AIFA grants market access for CTI's PIXUVRI to treat patients with aggressive B-cell NHL

Betaine boosts athletic performance by nearly 6%, study finds

Bioniche, Paladin close debt refinancing agreement and sign first licensing deal for Urocidin

Scientists explore biomedical applications in implants, drug delivery for hydrogel

St. Michael Hospital receives $4.7M grant to conduct policy-driven prescription drug research

New study could lead to better and more targeted drugs for arthritis and cancer

Researchers develop new tool to promote improved drug development

Oncologist urges drug companies to include key information in cancer drug labels

Duke researchers solve some mysteries related to the use of aspirin

Gerovital H3 may be making a comeback, warns BUSM researcher

Employers worry they'll pay bill for those exempt from contraceptive mandate

GAPVAC aims to develop personalized therapeutic vaccines for cancer

FDA approves Orexo's Zubsolv for people suffering from opioid dependence

Research shows lower daily dose of HIV drug therapy suppresses virus

Scientists uncover easy strategies to prevent harmful side-effects of antibiotics responses

Viewpoints: Dems' abortion policies on the wrong side of public opinion; Doctors need to be more accurate in death reports

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News